1. Home
  2. XELB vs PULM Comparison

XELB vs PULM Comparison

Compare XELB & PULM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Xcel Brands Inc.

XELB

Xcel Brands Inc.

HOLD

Current Price

$2.14

Market Cap

10.6M

Sector

Miscellaneous

ML Signal

HOLD

Logo Pulmatrix Inc.

PULM

Pulmatrix Inc.

HOLD

Current Price

$1.26

Market Cap

9.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
XELB
PULM
Founded
2011
2003
Country
United States
United States
Employees
N/A
N/A
Industry
Multi-Sector Companies
Biotechnology: Pharmaceutical Preparations
Sector
Miscellaneous
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
10.6M
9.4M
IPO Year
2011
2013

Fundamental Metrics

Financial Performance
Metric
XELB
PULM
Price
$2.14
$1.26
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$3.00
N/A
AVG Volume (30 Days)
47.6K
50.3K
Earning Date
04-07-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
48.37
46.18
EPS
N/A
N/A
Revenue
N/A
$7,910,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$83.93
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
5069.93
52 Week Low
$0.74
$1.16
52 Week High
$4.20
$9.37

Technical Indicators

Market Signals
Indicator
XELB
PULM
Relative Strength Index (RSI) 65.99 32.88
Support Level $1.29 $1.20
Resistance Level $2.23 $4.97
Average True Range (ATR) 0.21 0.12
MACD 0.07 0.02
Stochastic Oscillator 96.63 25.81

Price Performance

Historical Comparison
XELB
PULM

About XELB Xcel Brands Inc.

Xcel Brands Inc is a media and brand management company. It is engaged in design, merchandising and planning, sourcing and production, licensing, marketing, and brand development. The company offers branded apparel, footwear, accessories, jewelry, home goods, and other consumer products. Its brand portfolio consists of the Isaac Mizrahi, Judith Ripka, H Halston, C Wonder, and the Highline Collective brands. The company licenses its brands to third parties, provides certain designs, production, and marketing services, and generates licensing, design, and service fee revenues through contractual arrangements and other agreements.

About PULM Pulmatrix Inc.

Pulmatrix Inc is a biopharmaceutical company that has focused on the development of novel inhaled therapeutic products intended to prevent and treat migraine and respiratory diseases with important unmet medical needs using its patented dry powder delivery technology, iSPERSE. Its pipeline of clinical assets includes PUR3100 for the treatment of acute migraine, PUR1800 for the treatment of acute exacerbations of chronic obstructive pulmonary disease (AECOPD), and PUR1900 for the treatment of ABPA in patients with asthma and in patients with cystic fibrosis (CF).

Share on Social Networks: